Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Mesenchymal Stem Cells Market In 2029?

In recent times, there has been a swift expansion in the market size of mesenchymal stem cells. The forecast suggests a growth from $3.38 billion in 2024 to $3.82 billion in 2025, representing a compound annual growth rate (CAGR) of 13.0%. Factors contributing to this growth during the historic period include a paradigm shift towards regenerative medicine, increased collective research, heightened public consciousness about stem cell research and patient advocacy, international cooperation, and initiatives for standardization.

What Growth Rate Is Forecasted for the Mesenchymal Stem Cells Market by 2029?

Anticipated to witness rapid expansion, the mesenchymal stem cells market is projected to escalate to a value of $6.14 billion in 2029, with a compound annual growth rate (CAGR) of 12.6%. This substantial growth over the prediction period can be ascribed to ongoing advancements in genetic engineering, the uptake of personalized medicine solutions, the combination of AI and data analytics, progress in the field of biomaterials science and 3D bioprinting technologies, and the creation of microfluidic devices and organ-on-a-chip models. Other factors include the incorporation of next-gen manufacturing technologies. Key trends in this forecast period encompass bioprinting and tissue engineering, gene modification, the broadening of clinical application, combined therapy approaches, and the deployment of MSC-generated extracellular vesicles (EVs).

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16116&type=smp

Which Key Companies Are Shaping the Future of the Mesenchymal Stem Cells Market?

Major companies operating in the mesenchymal stem cells market are Thermo Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton, Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc., Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group, Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories, PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem Therapeutics Inc., American Cryostem Corporation

Which Factors Are Driving Demand in the Mesenchymal Stem Cells Industry?

The mesenchymal stem cells (MSC) market is expected to flourish as awareness about regenerative medicine rises. Regenerative medicine, an evolving interdisciplinary field, aims at the repair, replacement, or rebuilding of organs, tissues, or cells to restore functions lost due to causes such as congenital defects, trauma, aging, and disease. Factors such as growing instances of chronic and age-related conditions, personalized medicine, and increased clinical trials spur the growth of regenerative medicine. Due to their ability to develop into various cell types, regulate immune responses, and foster tissue repair and regeneration across a broad range of medical conditions, mesenchymal stem cells (MSCs) hold substantial potential in regenerative medicine. For example, a report by the Alliance for Regenerative Medicine revealed that in August 2023 there were 2,760 cells, gene, and tissue-engineering therapeutics developers globally in Q1 2023, a 101% rise from 1,369 in Q1 2022. A report presented by the American Society of Gene & Cell Therapy (ASGCT) and Citeline noted that by the end of Q1 2023, there were 247 gene therapies in Phase II which increased by 5% to 260 by the end of Q2 2023. Hence, the burgeoning awareness about regenerative medicine is fuelling the expansion of the mesenchymal stem cell (MSC) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16116&type=smp

How Is the Mesenchymal Stem Cells Market Segmented by Several Divisions?

The mesenchymal stem cells market covered in this report is segmented –

1) By Type: Autologous, Allogeneic

2) By Product Type: Cells And Cell Lines, Kits, Media And Reagents, Other Product Types

3) By Workflow Type: Cell Sourcing And Isolation, Culture And Cryopreservation, Differentiation, Characterization

4) By Indication: Bone And Cartilage Repair, Cardiovascular Diseases, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Other Indications

5) By Application: Disease Modeling, Drug Development And Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other Applications

Subsegments:

1) By Autologous: Bone Marrow-Derived, Adipose Tissue-Derived, Cord Blood-Derived, Peripheral Blood-Derived

2) By Allogeneic: Bone Marrow-Derived, Umbilical Cord-Derived, Placental-Derived, Induced Pluripotent Stem Cells (iPSCs) Derived, Wharton’s Jelly-Derived

What are the Emerging Market Trends Driving the Growth of the Mesenchymal Stem Cells Industry?

To cement their market position in the mesenchymal stem cells (MSCs) sector, major firms are implementing innovative technologies, including GMP-compliant isolation. This process, regulated by Good Manufacturing Practice (GMP), ensures the consistent isolation of cells, including MSCs for reliable quality control and production. In a case in point, PromoCell, a German biotechnology firm, in July 2023 announced the introduction of PromoExQ MSC Growth Medium XF. This is a serum- and xeno-free medium custom-made for human MSCs’ expansion within a GMP-controlled setting. Manufactured under strict quality standards, this medium has an EXCiPACT GMP certificate, guaranteeing regular MSC growth and maintenance from miscellaneous sources like bone marrow, umbilical cord matrix, and adipose tissue.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/mesenchymal-stem-cells-global-market-report

Which Regions Are Driving Growth in the Mesenchymal Stem Cells Market?

North America was the largest region in the mesenchymal stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16116

This Report Delivers Insight On:

1. How big is the mesenchymal stem cells market, and how is it changing globally?

2. Who are the major companies in the mesenchymal stem cells market, and how are they performing?

3. What are the key opportunities and risks in the mesenchymal stem cells market right now?

4. Which products or customer segments are growing the most in the mesenchymal stem cells market?

5. What factors are helping or slowing down the growth of the mesenchymal stem cells market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model